Summary of clinical characteristics and serum mesothelin levels in six patients with peritoneal mesothelioma who underwent surgical debulking and continuous hyperthermic peritoneal perfusion with cisplatin
| Patient | Gender | Age | Pathology | Mesothelin expression | Ascites | Debulked (%) | Mesothelin levels (ng/mL) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | POD 1 | POD 7 | |||||||||
| A | M | 68 | Epithelial | Yes | Yes | 95 | 22.2 | 5.5 | <1 | ||
| B | M | 63 | Epithelial | Yes | Yes | 70 | 24 | <1 | <1 | ||
| C | F | 52 | Epithelial | Yes | No | 80 | 11.3 | 11.2 | <1 | ||
| D | F | 31 | Epithelial | Yes | Yes | 10 | 41.6 | 34.4 | 26 | ||
| E | M | 46 | Biphasic | No | No | 90 | <1 | <1 | <1 | ||
| F | M | 51 | Epithelial | Yes | No | 100 | <1 | <1 | <1 | ||
Abbreviation: POD, postoperative day.